The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; 34 of the 141 sources its claims cite were checked for support.
Administrative criteria in the relapse of depressive disorder: a critical appraisal
Open accessAbstract
Background: Major depressive disorder (MDD) is a leading cause of disability globally, with high relapse rates. Currently, there is no standardized consensus on administrative criteria for defining relapses in MDD. Methods: A comprehensive literature search was conducted for texts published from January 1980 to April 2026. Articles were included if they described a depressive episode/major depressive episode or unipolar depression. The initial electronic search identified 4148 documents, and 51 were finally included in this review. Results: Over two thirds of the articles focus directly on relapse of MDD, either describing the overall prognosis of the disorder in various populations, the outcome of a given intervention, or the impact of certain factors. 44 of the 51 articles provide a definition of relapse based on either clinical criteria, psychometric measures or what we will establish as administrative criteria. Among those who use scales for definition there is not much uniformity. Among the administrative criteria the most cited is hospitalization, followed by changes in treatment and the need for electroconvulsive therapy. Conclusions: We suggest a conceptual model based on these criteria to define relapse in depression by drawing some preliminary conclusions: A minimum period of time from the remission of the previous episode to the emergence of what is considered a relapse is necessary, as well as the presence of at least one high-specificity criterion-hospitalization (including emergency room visit), ECT, or suicide attempt-and, in a complementary role, structured pharmacological changes that reflect guideline-based therapeutic steps.
Overview
CoChat Summary
TL;DR
This critical review of 51 studies finds no standardized administrative definition of relapse in major depressive disorder and proposes a preliminary operational framework. It suggests a minimum 90-day interval after remission plus at least one high-specificity criterion—hospitalization/emergency visit, ECT, or suicide attempt—with guideline-based pharmacological changes as complementary.
Key findings
- The initial search identified 4148 documents; 51 articles were included, and 44 of 51 (86.3%) provided a definition of relapse based on clinical, psychometric, or administrative criteria.
- Hospitalization was the most cited administrative criterion, mentioned in 42 of 51 articles (82.3%), followed by antidepressant treatment changes, suicide/suicide attempt (19 mentions), need for ECT (13 mentions), and emergency visit (3 mentions).
- Psychometric definitions were heterogeneous: 13 of 20 scale-based studies used the Hamilton Depression Rating Scale with thresholds ranging from 8 to 20 points; 7 used the Montgomery-Asberg Depression Rating Scale with thresholds of 15, 18, 21 or a 50% increase, or ≥22 for 2 consecutive weeks.
- Fourteen studies provided extractable time-to-relapse estimates: medians ranged from 53–90 days in severe or treatment-resistant samples to 218–294 days in maintenance-treated populations, and the median of study-level medians was approximately 90 days.
Methods
- A comprehensive MEDLINE search covered January 1980 to April 2026 using MeSH terms for depressive disorder, relapse/recurrence, and administrative indicators such as hospitalization, emergency visits, missed appointments, and outpatient visits; titles and abstracts were screened.
- Inclusion required English or Spanish publication, adult cases, a depressive episode/major depressive episode or unipolar depression, and diagnoses by specialized mental health personnel; retrospective, prospective, and clinical trials were included, while case-control studies, bipolar depression, pediatric samples, case series, conference abstracts, and doctoral theses were excluded.
- From 4148 records, 448 articles met criteria after abstract review and 51 were included; the review extracted definitions and administrative criteria, and for time-to-relapse estimates it recorded median time from remission to first relapse when available or the closest equivalent, then calculated the median of study-level medians.
Limitations
- The authors state the proposal is an initial approximation; the extended search timeframe may have introduced changes in diagnostic criteria, clinical practices, and social contexts that could affect comparability, though this was not explicitly analysed.
- The authors state the included studies are substantially heterogeneous, limiting direct comparison and generalizable conclusions; suicide attempts lack diagnostic specificity and may reflect personality disorders, substance use, psychosocial crises, or adjustment disorders; and the temporal threshold was derived only from the subset of studies with extractable time-to-relapse estimates, which may introduce bias.
- The authors also state that distinguishing relapse from symptom persistence or fluctuation is difficult in chronic or unstable depressive trajectories; evident from the text, administrative criteria may underdiagnose milder relapse, while clinical interviews and symptom scales may overdiagnose transient fluctuations, and the proposed framework requires prospective validation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
18 Valid · 5 Not valid · 15 Not checked · 35 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Suicide/suicide attempt is mentioned 19 times (1, 15, 16, 18, 19, 26, 27, 33, 37, 38, 41, 43–46, 48–50, 52)”
§ Administrative criteria in the relapse of depressive disorder: a critical appraisal > Results > Administrative criteria
What the sources say
- Supportedcites [1] Touya, 2022, Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data, BMC Psychiatry source
The Methods > Study population passage says that a suicide attempt confirmed in the claims database was one criterion for classifying a patient as having relapsed. The “19 times” count refers to the citing document’s list of references, not a count attributed to this individual source. (LLM, conf=0.91)
- Supportedcites [15] Durgam, 2019, Relapse prevention with levomilnacipran ER in adults with major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study, Depress Anxiety source
In Materials and Methods > Participants (page unavailable), the paper names a suicide attempt within the past 12 months as a criterion for exclusion. It also lists investigator-determined suicide risk among the criteria for relapse in Materials and Methods > Efficacy assessments. The 19 refers to the citing document’s list of papers, not a count attributed to this individual source. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [16] Verwijk, 2015, Relapse and long-term cognitive performance after brief pulse or ultrabrief pulse right unilateral electroconvulsive therapy: a multicenter naturalistic follow up, J Affect Disord source
- Not checked — no full text of the sourcecites [18] Rosenthal, 2013, Efficacy and safety of desvenlafaxine 50 mg/d for prevention of relapse in major depressive disorder: a randomized controlled trial, J Clin Psychiatry source
- Not checked — no full text of the sourcecites [19] Lambrichts, 2022, Long-term outcome following electroconvulsive therapy for late-life depression: five-year follow-up data from the MODECT study, Am J Geriatr Psychiatry source
- Not checked — no full text of the sourcecites [26] Kim, 2011, The effects of continuous antidepressant treatment during the first 6 months on relapse or recurrence of depression, J Affect Disord source
- Not checked — no full text of the sourcecites [27] Melfi, 1998, The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression, Arch Gen Psychiatry source
- Not checked — no full text of the sourcecites [33] Åkerblad, 2006, Response, remission and relapse in relation to adherence in primary care treatment of depression: a 2-year outcome study, Int Clin Psychopharmacol source
- Not checked — no full text of the sourcecites [37] Goodwin, 2009, Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial, J Clin Psychiatry source
- Not checked — no full text of the sourcecites [38] Prudic, 2004, Effectiveness of electroconvulsive therapy in community settings, Biol Psychiatry source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Nevertheless, multiple studies have shown a statistically significant association between relapse and hospitalization or emergency presentations (1).”
§ Administrative criteria in the relapse of depressive disorder: a critical appraisal > Discussion > Establishing the importance of each administrative criterion described and the necessity of their presence to consider an episode as a relapse
What the sources say
- Supportedcites [1] Touya, 2022, Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data, BMC Psychiatry source
The Discussion (page unavailable) explicitly reports statistically significant associations between relapse and higher rates of hospitalization and ED visits in this study. It also describes a separate retrospective study with significantly higher health care utilization among patients with relapse and more than twice the rates of ED visits and inpatient admissions. (LLM, conf=0.86)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“and 40 define it based on what we will establish as administrative criteria (1, 4, 7, 9, 11–13, 15–29, 33, 34, 38, 39, 42–50, 52–55).”
§ Administrative criteria in the relapse of depressive disorder: a critical appraisal > Results > Definitions provided for the concept of relapse
What the sources say
- Supportedcites [1] Touya, 2022, Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data, BMC Psychiatry source
The Methods (Study population; page not provided) define relapse using events recorded in a claims database or antidepressant reinitiation after a prescription gap. The Abstract (Methods; page not provided) identifies the data as administrative medical and pharmacy claims, so this paper is an example of a study using administrative criteria. It does not itself establish the citing document’s count of 40 articles. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [4] Blackburn, 1986, A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both, J Affect Disord source
- Not checked — no full text of the sourcecites [7] Appleton, 2021, Omega-3 fatty acids for depression in adults, Cochrane Database Syst Rev source
- Not checked — no full text of the sourcecites [9] Mundt, 2000, Reconfirming the role of life events for the timing of depressive episodes, J Affect Disord source
- Not checked — no full text of the sourcecites [11] Hooley, 1989, Predictors of relapse in unipolar depressives: Expressed emotion, marital distress, and perceived criticism, J Abnorm Psychol source
- Not checked — no full text of the sourcecites [12] Hooley, 1986, Levels of expressed emotion and relapse in depressed patients, Br J Psychiatry source
- Not checked — no full text of the sourcecites [13] Lin, 2020, Comparison of the efficacy of electroconvulsive therapy (ECT) plus agomelatine to ECT plus placebo in treatment‐resistant depression, Acta Psychiatr Scand source
- Supportedcites [15] Durgam, 2019, Relapse prevention with levomilnacipran ER in adults with major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study, Depress Anxiety source
This citation identifies one of the articles counted by the citing authors, not a source for the total of 40. In Materials and Methods (Efficacy assessments), the study defines relapse partly by hospitalization for worsening depression or an investigator-determined need for alternative antidepressant treatment, alongside symptom-score criteria. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [16] Verwijk, 2015, Relapse and long-term cognitive performance after brief pulse or ultrabrief pulse right unilateral electroconvulsive therapy: a multicenter naturalistic follow up, J Affect Disord source
- Not checked yetcites [17] Rosenberg, 2015, Long-term follow-up of MDD patients who respond to deep rTMS: a brief report, Isr J Psychiatry Relat Sci
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“There are studies that define relapse based on interviews with patients by collecting reappearance of symptoms (7–12, 41–43) or passing scales and comparing changes in the score with respect to previous evaluations (4, 7, 13–18, 42–49). This method may lead to overdiagnosis of recurrences.”
§ Administrative criteria in the relapse of depressive disorder: a critical appraisal > Introduction > Justification of the study
What the sources say
- Not checked — no full text of the sourcecites [7] Appleton, 2021, Omega-3 fatty acids for depression in adults, Cochrane Database Syst Rev source
- Partly supportedcites [8] Moksnes, 2011, Relapse following electroconvulsive therapy, Tidsskr Nor Laegeforen sourceExperimental — accuracy not yet measured
Materiale og metode (page not specified) defines relapse as a clear return of depressive symptoms documented in medical records. It does not describe defining relapse through patient interviews or changes in scale scores. Styrke og svakhet (page not specified) raises the possibility of missed relapses, not overdiagnosis, so the claim’s warning about overdiagnosis is not supported by this paper. (LLM, conf=0.82)
- Not checked — no full text of the sourcecites [9] Mundt, 2000, Reconfirming the role of life events for the timing of depressive episodes, J Affect Disord source
- Not checked — no full text of the sourcecites [10] O’Leary, 2000, Remission onset and relapse in depression. An 18-month prospective study of course for 100 first admission patients, J Affect Disord source
- Not checked — no full text of the sourcecites [11] Hooley, 1989, Predictors of relapse in unipolar depressives: Expressed emotion, marital distress, and perceived criticism, J Abnorm Psychol source
- Not checked — no full text of the sourcecites [12] Hooley, 1986, Levels of expressed emotion and relapse in depressed patients, Br J Psychiatry source
- Not checked — no full text of the sourcecites [41] Del Casale, 2025, Esketamine combined with SSRI or SNRI for treatment-resistant depression, JAMA Psychiatry source
- Not checked — no full text of the sourcecites [42] Cheng, 2025, The N-3 polyunsaturated fatty acids supplementation to prevent depression recurrence in patients with late-life depression: a 52-week double-blind, placebo-controlled trial, J Affect Disord source
- Supportedcites [43] Young, 2025, Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial, Br J Psychiatry source
The citation is attached to the scale-based definition of relapse, not to the separate sentence proposing overdiagnosis. The Outcomes section (p. 3) defines relapse using a MADRS threshold at two consecutive assessments and describes an alternative CGI-S threshold. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [4] Blackburn, 1986, A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both, J Affect Disord source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“20 do so with psychometric measures (Hamilton Depression Rating Scale, Beck Depression Inventory, Montgomery-Asberg Depression Rating Scale, Goldberg Anxiety and Depression Scale, Clinical Global Impression) (4, 7, 9, 13–18, 33, 34, 42–49)”
§ Administrative criteria in the relapse of depressive disorder: a critical appraisal > Results > Definitions provided for the concept of relapse
What the sources say
- Not checked — no full text of the sourcecites [4] Blackburn, 1986, A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both, J Affect Disord source
- Not checked — no full text of the sourcecites [7] Appleton, 2021, Omega-3 fatty acids for depression in adults, Cochrane Database Syst Rev source
- Not checked — no full text of the sourcecites [9] Mundt, 2000, Reconfirming the role of life events for the timing of depressive episodes, J Affect Disord source
- Not checked — no full text of the sourcecites [13] Lin, 2020, Comparison of the efficacy of electroconvulsive therapy (ECT) plus agomelatine to ECT plus placebo in treatment‐resistant depression, Acta Psychiatr Scand source
- Not checked — no full text of the sourcecites [14] Yang, 2020, Risk factors of relapse after successful electroconvulsive therapy for Taiwanese patients with major depression, J ECT source
- Supportedcites [15] Durgam, 2019, Relapse prevention with levomilnacipran ER in adults with major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study, Depress Anxiety source
The Efficacy assessments section defines relapse partly using psychometric measures: an increase in Clinical Global Impression of Severity score or a Montgomery–Åsberg Depression Rating Scale score of at least 18 at two consecutive visits. This supports citing the study as one of the articles that define relapse using such measures; the paper does not itself establish the citing review’s count of 20 articles. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [16] Verwijk, 2015, Relapse and long-term cognitive performance after brief pulse or ultrabrief pulse right unilateral electroconvulsive therapy: a multicenter naturalistic follow up, J Affect Disord source
- Not checked yetcites [17] Rosenberg, 2015, Long-term follow-up of MDD patients who respond to deep rTMS: a brief report, Isr J Psychiatry Relat Sci
- Not checked — no full text of the sourcecites [18] Rosenthal, 2013, Efficacy and safety of desvenlafaxine 50 mg/d for prevention of relapse in major depressive disorder: a randomized controlled trial, J Clin Psychiatry source
- Not checked — no full text of the sourcecites [33] Åkerblad, 2006, Response, remission and relapse in relation to adherence in primary care treatment of depression: a 2-year outcome study, Int Clin Psychopharmacol source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
20 more claims · 2 with their cited sources checked
Create a free account to see all 73 claims and to verify the 4 references still open.
- It may state two separate claims as one. 33
- Probably not a substantial claim. 26
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“in the last 45 years (from 1980 to 2026)”
§ Administrative criteria in the relapse of depressive disorder: a critical appraisal > Results
Reported 45 · recomputed 46
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Administrative criteria in the relapse of depressive disorder: a critical appraisal > Results > Study characteristics
“| Brakemeier EL, et al | 2025 | Germany | Both | 396 | 1.3 | Clinical trial | Hospitalization |”
§ Administrative criteria in the relapse of depressive disorder: a critical appraisal > References
“47. Brakemeier E-L Klein JP Zimmermann J Hollandt M Reinhard MA Boger S. Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial. BMJ Open. (2026) 16: e107051.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Administrative criteria in the relapse of depressive disorder: a critical appraisal > Results > Study characteristics
“| Li F, et al (53) | 2025 | Netherlands | Outpatients | 6863 | 10 | Descriptive retrospective | New treatment episode following a 6-month service-free |”
§ Administrative criteria in the relapse of depressive disorder: a critical appraisal > References
“53. Li F Shi Q Visser E Schoevers RA Feenstra T Jörg F. Modeling effect: how treatment intensity and duration impact depression recurrence. Eur Psychiatry. (2026) 69: e9.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Administrative criteria in the relapse of depressive disorder: a critical appraisal > Results > Study characteristics
“| Young A, et al (43) | 2024 | Multinational | NA | 676 | 0.66 | Clinical trial | Hospital admission Suicide or suicide attempt |”
§ Administrative criteria in the relapse of depressive disorder: a critical appraisal > References
“43. Young AH Llorca PM Fagiolini A Falkai P Cardoner N Nielsen RE. Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial. Br J Psychiatry. (2025) 226: 72–8.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Administrative criteria in the relapse of depressive disorder: a critical appraisal > Results > Study characteristics
“| Lisha I, et al (50) | 2026 | US | Inpatients | 159 | 2 | Descriptive retrospective | HospitalizationSuicide or suicide attempt AD (change)Necessitiy of ECT Requirement for additional neuromodulation interventions |”
§ Administrative criteria in the relapse of depressive disorder: a critical appraisal > References
“50. Lisha I Godbole Kroger NB Tsalatsanis A Norred MA Daneman LEW Tindall B. The durability of response to transcranial magnetic stimulation in veterans with major depressive disorder. J Affect Disord. (2025) 360: 121032.”
2 more findings
Create a free account to see every finding of this check.
Citations
Cites
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 2×
“When trying to de fi ne the concept of relapse, we often encounter conceptual dif fi culties (4, 5).”
Hooley, J. M., & Teasdale, J. D. (1989) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.98.3.229 · Cited by 740
Levels of expressed emotion and relapse in depressed patients
Hooley, J. M., Orley, J., & Teasdale, J. D. (1986) · British Journal of Psychiatry · doi:10.1192/bjp.148.6.642 · Cited by 499 · cited 1×
“There are studies that de fi ne relapse based on interviews with patients by collecting reappearance of symptoms (7 – 12, 41 – 43) or passing”
Melfi, C. A., Chawla, A. J., Croghan, T. W., Hanna, M. P., Kennedy, S., & Sredl, K. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.12.1128 · Cited by 409 · cited 1×
“The second criterion with which most authors agree is that related to antidepressant treatment, although some mention it in general (27, 33) and others specify whether they consider a change of antidepressant (8, 15, 26, 34, 40, 42, 48, 50), an upward adjustment (10, 17, 40, 45), a review of the…”
Goodwin, G. M., Emsley, R., Rembry, S., Rouillon, F., & the Agomelatine Study Group (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04548 · Cited by 340
BLACKBURN, I., EUNSON, K., & BISHOP, S. (1986) · Journal of Affective Disorders · doi:10.1016/0165-0327(86)90050-9 · Cited by 338 · cited 1×
“When trying to de fi ne the concept of relapse, we often encounter conceptual dif fi culties (4, 5).”
Effectiveness of electroconvulsive therapy in community settings
Prudic, J., Olfson, M., Marcus, S. C., Fuller, R. B., & Sackeim, H. A. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.09.015 · Cited by 269
Kessing, L. V., Hansen, M. G., Andersen, P. K., & Angst, J. (2004) · Acta Psychiatrica Scandinavica · doi:10.1046/j.1600-0447.2003.00266.x · Cited by 258 · cited 1×
“Also, the more depressive episodes, the higher the probability of relapse (3).”
Management of Depression in Adults: A Review
Simon, G. E., Moise, N., & Mohr, D. C. (2024) · JAMA · doi:10.1001/jama.2024.5756 · Cited by 234 · cited 1×
“Current evidence indicates that only approximately 35 – 45% of patients achieve symptomatic remission following antidepressant treatment in real − world settings (56).”
Okereke, O. I., Reynolds, C. F., Mischoulon, D., Chang, G., Vyas, C. M., Cook, N. R., Weinberg, A., Bubes, V., Copeland, T., Friedenberg, G., et al. (2020) · JAMA · doi:10.1001/jama.2020.10224 · Cited by 171
Metadata
- Authors
- Bernal-Cueto, S., Cegla-Schvartzman, F., & Baca-García, E.
- Affiliations
- Hospital Universitario Fundación Jiménez Díaz (ES)
- Department of Psychiatry, Jimenez Diaz Foundation Hospital
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2026-08-18
- Volume
- 17
- Pages
- 1796386-1796386
- ISSN
- 1664-0640 (ISSN-L)
- PMC
- PMC13548797
- OpenAlex
- W7203725857
- Cited by
- 0
- References
- 55
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- European Commission
- Instituto de Salud Carlos III (PMP24/00026, ISCIII PI23/00614, PI23/00614)
- European Regional Development Fund (PI23/00614, ISCIII PI23/00614)
- NextGenerationEU
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- major depressive disorder, relapse, hospitalization, electroconvulsive therapy, suicide attempts, remission, treatment modification
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Administrative criteria in the relapse of depressive disorder: a critical appraisal. https://app.cochat.ai/papers/10.3389/fpsyt.2026.1796386
- The paper
- Bernal-Cueto, S., Cegla-Schvartzman, F., & Baca-García, E. (2026). Administrative criteria in the relapse of depressive disorder: a critical appraisal. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2026.1796386
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.